Merck & Co Inc

MRK

$81.15

+7.6% (1 year change)

Market Cap

$205 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$15.05 - $84.56

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

36.89x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$2.57 (3.16%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $205 Billion
Enterprise Value $223 Billion
Dividend Yield $2.57 (3.16%)
1 Year Return +10.7%
52-Week High $84.56
52-Week Low $15.05
Beta 0.42
Outstanding Shares 2.53 Billion
Avg 30 Day Volume 19.9 Million

Valuation

P/E Ratio 36.89
PEG -76.01
Earnings per Share $2.12
Price to Sales Ratio 4.27
Price to Book Ratio 6.24
Revenue to Enterprise Value 4.6
EBIT to Enterprise Value 34.11
Total Debt to Enterprise Value 0.12
Debt to Equity 0.8

Profitability

Revenue $48.5 Billion
Gross Profit $32.8 Billion
EBIT $6.55 Billion
Net Income $5.57 Billion
Profit Margin 11.47%
Quarterly Earnings Growth (YoY) -48.5%
Return on Equity 16.73%
Return on Assets 6.14%
Return on Invested Capital 9.52%

Insider trades

No purchases

No sells

No purchases

19,324 shares sold (1 transactions)

No purchases

No sells

No purchases

No sells

Q1 2021 Q2 2021 Q3 2021 Q4 2021

About Merck & Co Inc

CEO: Kenneth Frazier

Industry: Pharmaceutical Preparation Manufacturing

Similar stocks

Pfizer Inc.
Johnson & Johnson
Lilly(Eli) & Co
Sanofi - ADR
Glaxosmithkline plc - ADR
Teva- Pharmaceutical Industries Ltd. - ADR
Novartis AG - ADR
Abbott Laboratories
AMGEN Inc.

News

Can Merck''s Antiviral for COVID Succeed Where Gilead''s Failed?

Can Merck''s Antiviral for COVID Succeed Where Gilead''s Failed?

Signs point to yes, but it''s still early in the game.

The Motley Fool The Motley Fool, 1 day ago
Veterinary Insulin Drugs Market  Growth, Trends, COVID-19 Impact, and Forecasts (2021  2027)| Allison Medical, Apotex, Becton, Dickinson and Company, Boehringer Ingelheim Vetmedica, Henry Schein Animal Health, MED TRUST, Merck, UltiMed

Veterinary Insulin Drugs Market Growth, Trends, COVID-19 Impact, and Forecasts (2021 2027)| Allison Medical, Apotex, Becton, Dickinson and Company, Boehringer Ingelheim Vetmedica, Henry Schein Animal Health, MED TRUST, Merck, UltiMed

The latest Veterinary Insulin Drugs market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The stu...

Jumbo News Jumbo News, 1 day ago
Covid pill: Gates Foundation allots $120 mln for poor nations to get Covid-19 drug

Covid pill: Gates Foundation allots $120 mln for poor nations to get Covid-19 drug

Oct 20 (Reuters) - The Gates Foundation will allocate up to $120 million to help lower-income countries get an experimental Covid-19 drug being developed by U.S. drugmaker Merck andamp; Co Inc in t...

Daily Maverick Daily Maverick, 4 days ago